Abstract

10002 Background: Survivors of childhood HR-ALL are at risk for neurocognitive deficits. The causes are multifactorial including treatment, host and environmental factors. This study evaluated the ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Improved Post-Induction Chemotherapy Does Not Abrogate Prognostic Significance of Minimal Residual Disease (MRD) for Children and Young Adults with High Risk Acute Lymphoblastic Leukemia (ALL). A Report From Children's Oncology Group (COG) Study AALL0232
Michael J Borowitz ... Eric C Larsen
Blood | VOL. 118
Michael J Borowitz, et. al.Michael J Borowitz ... Eric C Larsen
18 Nov 2011
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
Kristina K Hardy ... Wenjian Yang
Journal of Clinical Oncology | VOL. 35
Kristina K Hardy, et. al.Kristina K Hardy ... Wenjian Yang
03 Jul 2017
Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the Children's Oncology Group Study AALL0232
Michael J Burke ... Eric Larsen
Blood | VOL. 134
Michael J Burke, et. al.Michael J Burke ... Eric Larsen
13 Nov 2019
Patients with Down Syndrome and High-Risk B-Acute Lymphoblastic Leukemia Demonstrate Improved Outcomes on a Modified Chemotherapy Regimen: A Report from Children's Oncology Group Study AALL1131
Vilmarie Rodriguez ... Michael J Burke
Blood | VOL. 142
Vilmarie Rodriguez, et. al.Vilmarie Rodriguez ... Michael J Burke
28 Nov 2023
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers